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Oral submucous fibrosis (SMF) is an insidious,
chronic fibrotic change affecting any part of the
oral mucosa (Pindborg & Sirsat, 1966). Although
the exact aetiological factors responsible for such a
change are not known, chewing tobacco, betel nut
and slaked lime, either alone or wrapped in betel
leaf (Piper betel L.), is a predominant habit among
the SMF patients found in this part of Western
India. In recent years many authors have advocated
that SMF be considered as an oral precancerous
condition (Pindborg et al., 1968; WHO, 1984;
Pindborg et al., 1970). While analysing the case
histories of SMF patients so as to find out its
possible correlation with tobacco and betel nut
chewing habit, it was striking to note that some of
the individuals suffered the fibrotic change of oral
mucosa after adopting this chewing habit for more
than five years, whereas, others suffered this
consequence within a few months of commencing
chewing tobacco/betel nut. A further group of
individuals have been habitual chewers for more
than a decade, without experiencing any
appreciable change in the oral mucosa. This
indicates possible susceptibility to tobacco or betel
nut induced damage.
Sister chromatid exchange (SCE) frequency is an
easy, reproducible and sensitive marker of genomic
damage (Kato, 1977; Wolff, 1977). Baseline and
mutagen-induced SCE rates have been reported to be
significantly higher in individuals more prone to
develop cancer (Chaganti et al., 1974). With the
availability of these data, we have studied SCE
frequencies in untreated and Mitomycin C treated
lymphocyte cultures of controls, SMF patients and
frequency-duration matched normal chewers.
Controls were selected from the staff and the
blood bank donors. They did not consume tobacco
or betel nut in any form and had no viral disease
or antibiotic therapy during the preceding 6
months. Oral SMF was diagnosed when there was
a diffused and progressive fibrotic change in the
oral mucosa, characterised by stiffening of an
otherwise yielding mucosa, resulting in difficulty in
opening the mouth. For the sake of uniformity,
only those SMF patients who chewed a
combination of tobacco, betel nut and lime were
included for this study. The third group of
individuals were frequency and duration matched
chewers, free of any change in oral mucosa,
hereafter referred as normal chewers. Free and
informed consent of all individuals studied was
obtained before sample collection.
Peripheral blood was collected in heparinised
vials, under asceptic conditions. The samples were
coded by a person not involved in the subsequent
procedures. Details of the culture conditions, slide
preparations and staining procedures were
essentially the same as described earlier (Adhvaryu
et al., 1985). Briefly, 1.0ml whole blood was added
to 7.0ml growth medium which comprised of MEM
(Earle's base) with non essential amino acids
(Centron Lab. India) containing 20.0% goat serum.
To this, 100Uml-1 penicillin, 100pgml- strepto-
mycin, 0.3ml PHA-M (Gibco, USA) and 2.0pgml 1
BrdU (5-bromo deoxy uridine, Sigma Chem. Co.,
USA) were added. In another set of identical
cultures, MC (Biochem Pharm., India) was added at
a final concentration of 0.015pgml-1, at the start
of 72h incubation at 370 C. During the last 3h of
incubation, colchicine was added at a final concen-
tration of 0.3pgml-1. Slides were prepared by air
drying method following 0.56% KCI hypotonic and
aceto methanol fixation protocol. Sister chromatid
differential staining was achieved by FPG method.
Twenty five well spread metaphase cells in II
cycle were counted for calculating the mean SCE
value for each individual. Student's t test was
applied for determining significance levels.
Table I gives the details of baseline and MC
induced SCE values in all the three groups. Normal
chewers had 7.40 and SMF patients had 7.89 mean
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Table I Comparison of mean SCE per cell values in
different groups.
Baseline+s.e. MC induced+s.e.
Controls 6.16+0.167 20.60+0.684
Normal chewers 7.40+0.271a 21.22+0.439
SMF patients 7.89+0.279a 24.00+0.879b
ap<0 001; bP<0.01.
SCEs per cell, which were significantly higher
compared to 6.16SCE per cell value obtained for
the controls (P<0.001). It was noteworthy (Table
II) that among the controls only one individual had
>7.0 SCE per cell, whereas, among the normal
chewers 7/10 and among SMF patients, 9/10
individuals studied had >7.0 SCEs per cell.
MC induced mean SCE per cell value was 24.00
for SMF patients, which was significantly higher
compared to 20.60 SCE per cell value for the
controls (P<0.01), as well as 21.22 SCE per cell
value for the normal chewers (P<0.02).
For the further definition of the differences in the
3 groups, the total number of metaphase plates
counted were classified into different groups
according to number of SCEs per cell. Table III
provides the details of such a classification. SMF
patients had 16.0% and the normal chewers 11.5%
of total metaphase cells having > 10 baseline SCEs
compared to only 3.5% in the controls. Similarly,
for MC treated cultures, SMF patients had 37.0%
cells having >25 SCEs, compared to 13.0% and
20.0% values for normal chewers and controls,
respectively. It became evident from the data that
higher baseline and MC induced SCE values in the
lymphocytes of SMF patients were on account of
more cells with higher SCE values with a
concurrent drop in cells having lower SCE
frequencies.
Oral cancer is the most common form of cancer
among the Indian males. A positive association
between oral cancer and the habit of consuming
tobacco in various ways and chewing betel nut has
been reported on many occasions (WHO, 1984;
Mehta et al., 1969). Oral SMF is being strongly
advocated as a precancerous condition, which
Table II Details of individual SCE per cell values.
Subject
no. Age (yrs)/sex Baseline+s.e. MC induced+s.e.
Controls
1 21 M 6.03+0.43 20.72+0.45
2 22M 5.64+0.49 18.55+0.76
3 22F 6.86+0.46 22.81 +0.65
4 23M 6.20+0.43 20.31+1.09
5 23F 5.86+0.38 21.11+0.98
6 23 M 6.32+0.55 17.60+0.65
7 24M 6.28+0.47 18.52+0.68
8 27M 6.12+0.47 18.88+0.88
9 27 M 7.48+0.67 15.69+0.72
10 27 F 5.46+0.38 22.97+0.57
11 28M 5.29+0.39 20.98+0.91
12 30M 6.89+0.45 27.54+1.04
13 35M 6.85+0.38 21.81+0.54
14 42F 6.08+0.50 20.70+0.65
15 50M 4.99+0.42 20.85+0.56
Mean 28 6.16+0.167 20.60+0.684
Tobacco chewers
1 22M 7.94+0.62 21.21+0.40
2 25M 9.10+0.34 22.05+0.56
3 26M 5.88+0.32 19.87+0.34
4 28M 8.27+0.62 21.12+0.71
5 28M 7.40+0.48 23.48+1.13
6 33 M 6.65+0.38 18.60+0.78
7 35M 7.13+0.59 21.51+0.76
8 35 M 6.74+0.59
9 36M 7.28+0.40 21.91+0.79
10 37M 7.57+0.50 20.38+0.93
Mean 30 7.40+0.271 21.22+0.439
SMF patients
1 20M 8.33+0.43
2 21 M 9.25+0.59 29.13+1.01
3 22M 9.64+0.77 22.04+0.68
4 26M 7.30+0.34 20.30+0.59
5 26M 7.59+0.36
6 30M 7.20+0.59 24.40+0.90
7 30F 6.64+0.53 22.41+1.25
8 30M 7.43+0.49 23.74+0.91
9 35F 7.70+0.47 24.29+0.83
10 40M 7.82+0.49 25.69+0.89
Mean 28 7.89+0.279 24.00+ 0.879
Table III Percent distribution ofmetaphase plates according to number of SCEs.
Baseline SCE per metaphase MC induced SCE per metaphase
Group 0-5 6-10 11-15 16+ 0-15 16-20 21-25 26+
Controls 45.0 51.5 3.0 0.5 12.0 30.0 38.0 20.0
Normal chewers 26.5 62.0 11.0 0.5 8.5 42.5 36.0 13.0
SMF patients 23.0 61.0 15.0 1.0 2.0 27.0 34.0 37.0SCE STUDIES IN ORAL SU"MUCOUS FIBROSIS 143
probably renders the mucosa more vulnerable to
the action of carcinogens. The present study was
conducted with a view to find out whether SMF
patients can be identified as a separate class on the
basis of baseline or mutagen-induced SCE
frequencies. Baseline SCE rates have been reported
to be higher in patients with various malignant
diseases (Kurvink et al., 1978; Ottar et al., 1979;
Hopkins & Evans, 1980) and in Bloom's syndrome
patients, who are more prone to develop malignant
disorders (Chaganti et al., 1974). Mutagen-induced
SCE rates have been shown to be significantly
higher in the cells of patients with ataxia
telangiectasia (Sasaki, 1980) and Down's syndrome
(Sugimoto et al., 1982). These patients have been
identified as cancer prone individuals. Our results,
though on a very limited number of individuals,
permit us to assume that SMF patients have higher
baseline SCE frequencies compared to the controls.
However, they were not significantly different from
normal chewers on the basis of baseline SCE rates.
Tobacco contains nicotine, nornicotine and
anatabine, which are known to induce SCEs (Riebe
& Westphal, 1983). Cigarette smokers also have
been reported to have higher lymphocytic SCEs
compared to non smokers (Lambert et al., 1978).
Similarly, arecoline, a major betel nut alkaloid, has
been reported to have genotoxic effects and to
induce SCE rates (Stich et al., 1981; Panigrahi &
Rao, 1982). Thus higher baseline SCE rates in
normal chewers and SMF patients can be
attributed to the genotoxic effects of tobacco and
betel nut alkaloids.
Mitomycin C induced mean SCE value in SMF
patients was significantly higher compared to
controls as well as normal chewers. This indicates
that MC induced genomic damage, as assessed with
the SCE technique, is somehow more pronounced
in the cells of SMF patients. However, more
detailed studies, employing other mutagens and
more than one concentration of the same mutagen
are necessary before any conclusions about
involvement of susceptibility to tobacco/betel nut
induced changes in oral SMF patients can be
drawn.
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